Market Movers Today: Corcept Therapeutics Incorporated (CORT), Eyegate Pharmaceuticals Inc (EYEG), Arconic Inc (ARNC), and More

Wells Fargo & Co (NYSE:WFC) (MarketWatch)
Wells Fargo & Co. says the impact from sanctions put on the bank after a wave of customer account scandals could reduce its profit this year by as much as $400 million. Wells Fargo WFC, -8.53% is replacing four board members and won’t be able to grow beyond the $1.95 trillion in assets it held at the end of 2017, after agreeing to a consent order with the Federal Reserve on Friday. The bank opened millions of customer accounts without consent over a period of years, and it has also been found to have committed additional infractions, such as charging borrowers for unneeded guaranteed auto protection.

TOP SHIPS Inc (NASDAQ:TOPS) (Benzinga)
TOP SHIPS Inc surged 57.7 percent to $0.323 following FY17 results announced late Friday. The company posted net loss of $13.4 million on sales of $39.363 million.

Bristol-Myers Squibb Co (NYSE:BMY) (CNBC)
Bristol-Myers Squibb – The drugmaker reported adjusted quarterly profit of 68 cents per share, one cent a share above estimates. Revenue also beat forecasts and the company announced that its cancer drug Opdivo has been approved for use in patients with a certain type of melanoma. The company also did well in clinical trials as part of a combination treatment with certain lung cancer patients.

Pfizer Inc. (NYSE:PFE) (CNBC)
Pfizer – Pfizer has gotten only two bids for its consumer unit, according to a Bloomberg report. GlaxoSmithKline and Reckitt Benckiser are the only companies to bid, with rival candidates having walked away. Analysts say the unit could be worth between $15 billion and $20 billion.